▶ 調査レポート

世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測
• 英文タイトル：Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測 / Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2019-2025 / QYR9N7489資料のイメージです。• レポートコード：QYR9N7489
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、リソソーム蓄積症（LSD）のグローバル市場について調査・分析したレポートで、種類別（脂質代謝異常、糖タンパク質代謝異常）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・リソソーム蓄積症（LSD）の世界市場規模
・主要企業別市場シェア
・リソソーム蓄積症（LSD）の世界市場規模：種類別（脂質代謝異常、糖タンパク質代謝異常）
・リソソーム蓄積症（LSD）の世界市場規模：用途別（病院、診療所、その他）
・リソソーム蓄積症（LSD）のアメリカ市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）のヨーロッパ市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）の中国市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）の日本市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）の東南アジア市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）のインド市場規模（種類別、用途別）
・リソソーム蓄積症（LSD）の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・リソソーム蓄積症（LSD）の世界市場予測（2019年-2025年）
・リソソーム蓄積症（LSD）の地域別市場予測（2019年-2025年）
...

Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy. However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.
In 2018, the global Lysosomal Storage Disease (LSD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lysosomal Storage Disease (LSD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Disease (LSD) development in United States, Europe and China.

The key players covered in this study
Actelion Pharmaceuticals
Amicus Therapeutics
Arena Pharmaceuticals
Astellas Pharma
Astrazeneca
Biomarin Pharmaceutical
Eli Lilly
Lexicon Pharmaceuticals
Novo Nordisk
Merck

Market segment by Type, the product can be split into
Lipid Metabolism Disorder
Glycoprotein Metabolism Disorder

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lysosomal Storage Disease (LSD) status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Storage Disease (LSD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lysosomal Storage Disease (LSD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Lipid Metabolism Disorder
1.4.3 Glycoprotein Metabolism Disorder
1.5 Market by Application
1.5.1 Global Lysosomal Storage Disease (LSD) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lysosomal Storage Disease (LSD) Market Size
2.2 Lysosomal Storage Disease (LSD) Growth Trends by Regions
2.2.1 Lysosomal Storage Disease (LSD) Market Size by Regions (2014-2025)
2.2.2 Lysosomal Storage Disease (LSD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lysosomal Storage Disease (LSD) Market Size by Manufacturers
3.1.1 Global Lysosomal Storage Disease (LSD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Lysosomal Storage Disease (LSD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lysosomal Storage Disease (LSD) Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Storage Disease (LSD) Key Players Head office and Area Served
3.3 Key Players Lysosomal Storage Disease (LSD) Product/Solution/Service
3.4 Date of Enter into Lysosomal Storage Disease (LSD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019)
4.2 Global Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019)

5 United States
5.1 United States Lysosomal Storage Disease (LSD) Market Size (2014-2019)
5.2 Lysosomal Storage Disease (LSD) Key Players in United States
5.3 United States Lysosomal Storage Disease (LSD) Market Size by Type
5.4 United States Lysosomal Storage Disease (LSD) Market Size by Application

6 Europe
6.1 Europe Lysosomal Storage Disease (LSD) Market Size (2014-2019)
6.2 Lysosomal Storage Disease (LSD) Key Players in Europe
6.3 Europe Lysosomal Storage Disease (LSD) Market Size by Type
6.4 Europe Lysosomal Storage Disease (LSD) Market Size by Application

7 China
7.1 China Lysosomal Storage Disease (LSD) Market Size (2014-2019)
7.2 Lysosomal Storage Disease (LSD) Key Players in China
7.3 China Lysosomal Storage Disease (LSD) Market Size by Type
7.4 China Lysosomal Storage Disease (LSD) Market Size by Application

8 Japan
8.1 Japan Lysosomal Storage Disease (LSD) Market Size (2014-2019)
8.2 Lysosomal Storage Disease (LSD) Key Players in Japan
8.3 Japan Lysosomal Storage Disease (LSD) Market Size by Type
8.4 Japan Lysosomal Storage Disease (LSD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lysosomal Storage Disease (LSD) Market Size (2014-2019)
9.2 Lysosomal Storage Disease (LSD) Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Type
9.4 Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Application

10 India
10.1 India Lysosomal Storage Disease (LSD) Market Size (2014-2019)
10.2 Lysosomal Storage Disease (LSD) Key Players in India
10.3 India Lysosomal Storage Disease (LSD) Market Size by Type
10.4 India Lysosomal Storage Disease (LSD) Market Size by Application

11 Central & South America
11.1 Central & South America Lysosomal Storage Disease (LSD) Market Size (2014-2019)
11.2 Lysosomal Storage Disease (LSD) Key Players in Central & South America
11.3 Central & South America Lysosomal Storage Disease (LSD) Market Size by Type
11.4 Central & South America Lysosomal Storage Disease (LSD) Market Size by Application

12 International Players Profiles
12.1 Actelion Pharmaceuticals
12.1.1 Actelion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Storage Disease (LSD) Introduction
12.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.1.5 Actelion Pharmaceuticals Recent Development
12.2 Amicus Therapeutics
12.2.1 Amicus Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Storage Disease (LSD) Introduction
12.2.4 Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.2.5 Amicus Therapeutics Recent Development
12.3 Arena Pharmaceuticals
12.3.1 Arena Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Storage Disease (LSD) Introduction
12.3.4 Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.3.5 Arena Pharmaceuticals Recent Development
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Storage Disease (LSD) Introduction
12.4.4 Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.4.5 Astellas Pharma Recent Development
12.5 Astrazeneca
12.5.1 Astrazeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Storage Disease (LSD) Introduction
12.5.4 Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.5.5 Astrazeneca Recent Development
12.6 Biomarin Pharmaceutical
12.6.1 Biomarin Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Storage Disease (LSD) Introduction
12.6.4 Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.6.5 Biomarin Pharmaceutical Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Storage Disease (LSD) Introduction
12.7.4 Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 Lexicon Pharmaceuticals
12.8.1 Lexicon Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lysosomal Storage Disease (LSD) Introduction
12.8.4 Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.8.5 Lexicon Pharmaceuticals Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lysosomal Storage Disease (LSD) Introduction
12.9.4 Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.9.5 Novo Nordisk Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lysosomal Storage Disease (LSD) Introduction
12.10.4 Merck Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)
12.10.5 Merck Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lysosomal Storage Disease (LSD) Key Market Segments
Table Key Players Lysosomal Storage Disease (LSD) Covered
Table Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lysosomal Storage Disease (LSD) Market Size Market Share by Type 2014-2025
Figure Lipid Metabolism Disorder Figures
Table Key Players of Lipid Metabolism Disorder
Figure Glycoprotein Metabolism Disorder Figures
Table Key Players of Glycoprotein Metabolism Disorder
Table Global Lysosomal Storage Disease (LSD) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Lysosomal Storage Disease (LSD) Report Years Considered
Table Global Lysosomal Storage Disease (LSD) Market Size 2014-2025 (Million US$)
Figure Global Lysosomal Storage Disease (LSD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Size by Regions 2014-2025 (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Size by Regions 2014-2019 (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Disease (LSD) Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Disease (LSD) Market Share by Regions 2019
Table Market Top Trends
Table Global Lysosomal Storage Disease (LSD) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Share by Manufacturers (2014-2019)
Figure Global Lysosomal Storage Disease (LSD) Market Share by Manufacturers in 2018
Table Global Lysosomal Storage Disease (LSD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lysosomal Storage Disease (LSD) Product/Solution/Service
Table Date of Enter into Lysosomal Storage Disease (LSD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Size Share by Type (2014-2019)
Figure Global Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2014-2019)
Table Global Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table Global Lysosomal Storage Disease (LSD) Market Size Share by Application (2014-2019)
Figure Global Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Storage Disease (LSD) Revenue Market Share by Application in 2018
Figure United States Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table United States Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table United States Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table United States Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table United States Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table United States Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table United States Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure Europe Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table Europe Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table Europe Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table Europe Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table Europe Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure China Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table China Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table China Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table China Lysosomal Storage Disease (LSD) Market Size by Type (2014-20189) (Million US$)
Table China Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table China Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table China Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure Japan Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table Japan Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table Japan Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table Japan Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table Japan Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure Southeast Asia Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table Southeast Asia Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure India Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table India Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table India Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table India Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table India Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table India Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table India Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Figure Central & South America Lysosomal Storage Disease (LSD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lysosomal Storage Disease (LSD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lysosomal Storage Disease (LSD) Market Share (2018-2019)
Table Central & South America Lysosomal Storage Disease (LSD) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Disease (LSD) Market Share by Type (2014-2019)
Table Central & South America Lysosomal Storage Disease (LSD) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Disease (LSD) Market Share by Application (2014-2019)
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019) (Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table Amicus Therapeutics Company Details
Table Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Amicus Therapeutics Recent Development
Table Arena Pharmaceuticals Company Details
Table Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Arena Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Arena Pharmaceuticals Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Astellas Pharma Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Astrazeneca Recent Development
Table Biomarin Pharmaceutical Company Details
Table Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Biomarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Biomarin Pharmaceutical Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Eli Lilly Recent Development
Table Lexicon Pharmaceuticals Company Details
Table Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Lexicon Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Lexicon Pharmaceuticals Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Novo Nordisk Recent Development
Table Merck Company Details
Table Merck Revenue in Lysosomal Storage Disease (LSD) Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2014-2019)
Table Merck Recent Development
Table Global Lysosomal Storage Disease (LSD) Market Size by Regions (Million US$) 2019-2025
Figure Global Lysosomal Storage Disease (LSD) Market Size Share by Regions (2019-2025)
Figure Global Lysosomal Storage Disease (LSD) Market Size Share by Regions in 2025
Figure United States Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure China Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure India Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lysosomal Storage Disease (LSD) Market Size Forecast (2019-2025)(Million USD)
Table Global Lysosomal Storage Disease (LSD) Market Size by Product (2019-2025) (Million US$)
Figure Global Lysosomal Storage Disease (LSD) Market Size by Product (2019-2025)
Figure Global Lysosomal Storage Disease (LSD) Market Size by Product in 2025
Table Global Lysosomal Storage Disease (LSD) Market Size by Application (2019-2025) (Million US$)
Figure Global Lysosomal Storage Disease (LSD) Market Size by Application (2019-2025)
Figure Global Lysosomal Storage Disease (LSD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測
    Global Lysosomal Storage Diseases Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7490 2019年6月14日 97Pages
    当資料は、リソソーム蓄積症治療薬のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、幹細胞療法、基板削減療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測
    Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7488 2019年6月14日 97Pages
    当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界のハンチントン病の治療市場：市場規模・現状・予測
    Global Huntington’s Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7325 2019年6月14日 97Pages
    当資料は、ハンチントン病の治療のグローバル市場について調査・分析したレポートで、種類別（対症療法、疾患修飾療法）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界のウィルソン病薬市場：市場規模・現状・予測
    Global Wilson's Disease Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8198 2019年6月14日 93Pages
    当資料は、ウィルソン病薬のグローバル市場について調査・分析したレポートで、種類別（トリエンティン、D-ペニシラミン、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界のメニエール病治療市場：市場規模・現状・予測
    Global Meniere's Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7539 2019年6月14日 92Pages
    当資料は、メニエール病治療のグローバル市場について調査・分析したレポートで、種類別（薬、非侵襲的治療法と手順、中耳への注射、手術、その他）、用途別（病院、診療所、医学研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のメニエール病の薬市場：市場規模・現状・予測
    Global Meniere's Disease Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7538 2019年6月14日 96Pages
    当資料は、メニエール病の薬のグローバル市場について調査・分析したレポートで、種類別（乗り物酔いの薬、抗悪心薬、その他）、用途別（病院、診療所、医学研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の腎疾患の治療市場：市場規模・現状・予測
    Global Renal Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7951 2019年6月14日 97Pages
    当資料は、腎疾患の治療のグローバル市場について調査・分析したレポートで、種類別（急性腎臓の問題、慢性腎臓病、その他）、用途別（病院、診療所、リサーチセンター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。<...
  • 世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7362 2019年6月14日 98Pages
    当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...
  • 世界の腎疾患市場：市場規模・現状・予測
    Global Renal Disease Market Size, Status and Forecast 2019-2025
    QYR9N7950 2019年6月14日 99Pages
    当資料は、腎疾患のグローバル市場について調査・分析したレポートで、種類別（急性腎臓の問題、慢性腎臓病、その他）、用途別（病院、診療所、リサーチセンター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のクローン病治療薬市場：市場規模・現状・予測
    Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7041 2019年6月14日 95Pages
    当資料は、クローン病治療薬のグローバル市場について調査・分析したレポートで、種類別（非外科的、外科的）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・ク...
  • 世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測 Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Europe is estimated to be the domin…
  • 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測 Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31.In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and…
  • 世界の脂質障害治療市場2019世界の脂質障害治療市場2019 The global Lipid Disorder Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Lipid Disorder Treatment market status and forecast, categorizes the global Lipid Disorder Treatment marke…
  • 世界の代謝性疾患治療薬市場：市場規模・現状・予測世界の代謝性疾患治療薬市場：市場規模・現状・予測 Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.In 2018, the global Metabolic Disorder Therapeutics market size was xx million US$ and it is expected to reach xx mill…
  • 世界の色素沈着異常症の治療市場：市場規模・現状・予測世界の色素沈着異常症の治療市場：市場規模・現状・予測 Hypopigmentation is characterized specifically as an area of skin becoming lighter than the baseline skin color, but not completely devoid of pigment.In 2018, the global Hypopigmentation Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, …